Kai Van Lieshout discusses how AI scribes are transforming clinical practice, presenting both human stories and empirical evidence to show their impact on medical practitioners and the patient experience.
Tomaso Aste and Geoff Goodell from University College London’s Centre for Blockchain Technologies share their views on why blockchain technology is for the public good and about the fundamental design constraints and digital identity protocols in a human rights context
The fascinating research of Professor Brunhilde Wirth is placed under the spotlight, concerning her work in the field of disease-causing genes, modifier pathways and pathomechanisms of neuromuscular disorders, focussing on spinal muscular atrophy (SMA)
Peder Vejsig Pedersen & Miriam Sanchez Mayoral from Kuben Management profile an exciting project at Copenhagen International School (CIS) in Denmark that concerns an...
The importance of reviewing world food production systems for mankind is examined by Horticulturist at the Swedish University of Agriculture, Håkan Sandin in terms of the need for humanity to eat more healthy food and to produce it in a way that does not harm nature
Jon Snaedal, professor in Geriatric Medicine, Landspitali University Hospital in Reykjavik, Iceland shares his expertise on dementia research including the early diagnosis of brain disorders
Birgit Puschner and Pamela Lein from the University of California, Davis share their expert views on the impacts of urban wildfire on chemical contamination in small backyard agriculture.
Prof Colin J Suckling from the University of Strathclyde provides his seasoned opinion on a front-runner antibiotic for the treatment of Clostridium difficile associated diseases.
Prof Thomas Jaki, Professor of Statistics at Lancaster University’s Medical and Pharmaceutical Statistics Research Unit tells us about some practical considerations around evaluating multiple treatments for patients.
Associate Professor of Medicine, Anesthesiology and Critical Care at Université Clermont Auvergne, Matthieu Jabaudon assesses the RAGE pathway in at-risk critically ill patients and asks if this is a step towards better acute respiratory distress syndrome (ARDS) prediction
